NLC and Australia’s BioCurate announce Strategic Alliance for Commercialization of New Therapies

Amsterdam, July 19, 2023 The two will collaborate on development projects to bring new therapies to market. NLC, the European Healthtech Venture Builder based…

Read more

NLC sluit eerste ronde van het NLC Health Impact Fund

PERSBERICHT 28 juni 2023 NLC, de grootste Healthtech Venture Builder van Europa, kondigt met trots de sluiting van de eerste investeringsronde van het NLC…

Read more

IN THE NEWS: HEALTH IMPACT FUND INITIAL CLOSE

Following the successful initial close of our flagship NLC Health Impact Fund, NLC is proudly featured in the news. Business and financial news outlets…

Read more

NLC announces it has completed the initial close of the NLC Health Impact Fund

June 26, 2023 40 high-impact ventures will receive investments from the largest European healthtech venture builder following the successful initial close of its flagship…

Read more

INTRODUCING OCCLUNOVA: AN IMPLANTABLE DEVICE FOR CHRONIC ATRIAL FIBRILLATION (AF)

PRESS RELEASE June 23, 2023 Founded by NLC, OccluNova is developing an implantable LAA closure device for people with chronic atrial fibrillation (AF) Atrial…

Read more

INTRODUCING THERAGENIX: GENE-BASED TISSUE REGENERATION

PRESS RELEASE June 12, 2023 TherageniX, an NLC venture, delivers genes for tissue repair and regeneration Disease, injuries and aging can damage body tissues….

Read more

INTRODUCING PROVASCTEC : A CELL THERAPY FOR PATIENTS WITH CRITICAL LIMB ISCHEMIA

PRESS RELEASE March 20, 2023 ProVascTec, an NLC venture, will help patients  with critical limb ischemia by triggering cell induced new vascular tissue growth.   …

Read more

INTRODUCING HEAT2MOVE: A NON-MEDICAL AND NON-INVASIVE PAIN RELIEVING TECHNOLOGY

PRESS RELEASE March 6, 2023 HEAT2MOVE, an NLC venture, sets out to provide a home care chronic pain relief option that is based on…

Read more

INTRODUCING ANSANA: A NEW STERILIZATION TECHNOLOGY FOR THE HEALTHCARE & PHARMACEUTICAL INDUSTRY.

PRESS RELEASE February 28, 2023 Ansana, an NLC venture, is on a mission to develop and launch a cutting-edge system for observing and confirming…

Read more